Exabis Library
Welcome to the e-CCO Library!
P338: Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P339 Assessment of DNA-thioguanine nucleotide identifies patients at risk of thiopurine-induced leukopoenia in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P339: Application of Bayesian modelling with infliximab to determine optimal patient-specific regimens
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P339: Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P339: MadCAM1 expression in intestinal lamina propria endothelium varies among inflammatory bowel disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P339: Pregnant women with perianal Crohn’s Disease: suggestions for the improvement of the current guideline on delivery method
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P339: The efficacy of intravenous iron therapy in IBD patients with active disease is not influenced by the degree of inflammatory activity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P339: Zonulin concentration in patients with ulcerative colitis with and without COVID-19 infection
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P340 Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
Thursday, 24 February 2022, 4:23 PM by Dietrich Diz Angerer-GTN
P340: Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P340: Postoperative clinical recurrence in Crohn’s disease patients: the Practicrohn study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P340: Prevalence and long-term effect of antiplatelet use in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P340: Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn’s disease: A retrospective cohort database analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P340: Risankizumab in Inflammatory Bowel Disease: Real World Experience from a Pre-Approval Access Program
2021
ECCO'22
Friday, 11 February 2022, 3:52 PM
Friday, 4 March 2022, 1:42 PM by Dietrich Diz Angerer-GTN
P340: Serum albumin and C-reactive protein week 2/week 0 ratio after anti-TNF therapy best predict both short- and long-term clinical outcomes in anti-TNF-naïve ulcerative colitis patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P340: Vedolizumab in the treatment of chronic refractory pouchitis: a systematic review
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P341 Induction of response and remission: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P341: Analytical performance of a new iPhone-based patient monitoring system comparable to ELISA for measuring faecal calprotectin in inflammatory bowel disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P341: Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM